Back

DNA-guided CRISPR/Cas12 for RNA targeting

Orosco, C.; Rananaware, S. R.; Huang, B.; Hanna, M. P.; Ahmadimashhadi, M. R.; Lewis, J. G.; Baugh, M. P.; Bodin, A. P.; Flannery, S. J.; Lange, I. H.; Fang, Z. R.; Karalkar, V. N.; Meister, K. S.; Jain, P. K.

2024-11-22 genetic and genomic medicine
10.1101/2024.11.21.24317744 medRxiv
Show abstract

CRISPR-Cas nucleases are transforming genome editing, RNA editing, and diagnostics but have been limited to RNA-guided systems. We present {Psi}DNA, a DNA-based guide for Cas12 enzymes, engineered for specific and efficient RNA targeting. {Psi}DNA mimics a crRNA but with a reverse orientation, enabling stable Cas12-RNA assembly and activating trans-cleavage without RNA components. {Psi}DNAs are effective in sensing short and long RNAs and demonstrated 100% accuracy for detecting HCV RNA in clinical samples. We discovered that {Psi}DNAs can guide certain Cas12 enzymes for RNA targeting in cells, enhancing mRNA degradation via ribosome stalling and enabling multiplex knockdown of multiple RNA transcripts. This study establishes {Psi}DNA as a robust alternative to RNA guides, augmenting the potential of CRISPR-Cas12 for diagnostic applications and targeted RNA modulation in cellular environments.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.